[2] Arpin M,Chirivino D,Naba A,et al.Emerging role for ERM proteins in cell adhesion and igration[J].Cell Adh Migr,2011,5(2):199-206.
[2] Fehon RG,McClatchey AI,Bretscher A,et al.Organizing the cell cortex:the role of ERM proteins[J].Nat Rev Mol Cell Biol,2010,11(4):276-287.
[3] Zhu J,Feng Y,Ke Z,et al.Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin[J].Pathol,2012,180(6):2440-2451.
[4] Briggs JW,Ren L,Nguyen R,et al.The ezrin metastatic phenotype is associated with the initiation of protein translation [J].Neoplasia,2012,14(4):297-310.
[5] Heiska L,Melikova M,Zhao F,et al.Ezrin is key regulator of Srcinduced malignant phenotype in three-dimensional environment[J].Oncogene,2011,30(50):4953-4962.
[6] Janke M,Herrig A,Austermann J,et al.Actin binding of ezrin is activated by specific recognition of PIP2-funetionalized lipid bilayers[J].Biochemistry,2008,47(12):3762-3769.
[7] Meng Y,Lu Z,Yu S,et al.Ezrin promotes invasion and metastasis of pancreatic cancer cells[J].Transl Med,2010,8(1):61-75.
[8] Kang YK,Hong SW,Lee H,et al.Prognostic implications of ezrin expression in human hepatocellular carcinoma[J].Mol Carcinog,2010,49(9):798-804.
[9] Li L,Wang YY,Zhao ZS,et al.Ezrin is associated with gastric cancer progression and prognosis[J].Pathol Oncol Res,2011,17(4):909-915.
[10] Elzagheid A,Korkeila E,Bendardaf R,et al.Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer[J].Hum Pathol,2008,39(12):1737-1743.
[11] Madan R,Brandwein-Gensler M,Elias K,et al.Differential tissue and subcellular expression of ERM proteins in normal and malignant tissues:cytoplasmic ezrin expression has prognostic significance for head and neck squamous cell carcinoma[J].Head Neck,2006,28(11):1018-1027.
[12] Osawa H,Smith CA,Ra YS,et al.The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells [J].Neuro Oncol,2009,11(4):381-393.
[13] Li Q,Wu M,Wang H,et al.Ezrin silencing by small hairpin RNA reverses metastatic behaviors of human breast cancer cells[J].Cancer Lett,2008,261(1):55-63.
[14] Elliott BE,Meens JA,SenGupta SK,et al.The membrane cytoskeleton crosslinker ezrin is required for metastasis of breast carcinoma cells[J].Breast Cancer Res,2005,7(3):365-373.
[15] Mak H,Naba A,Varma S,et al.Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells[J].Cancer,2012,12(1):82-96.
[16] Bruce B,Khanna G,Ren L,et al.Expression of the cytoskeleton linker protein ezrin in human cancers[J].Clin Exp Metastasis,2007,24(2):69-78.
[17] Arslan AA,Silvera D,Arju R,et al.Atypical ezrin localization as a marker of locally advanced breast cancer[J].Breast Cancer Res Treat,2012,134(3):981-988.
[18] Sarrio D,Rodriguez-Pinilla SM,Dotor A,et al.Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas[J].Breast Cancer Res Treat,2006,98 (1):71-79.